Hi All
Nothing in here suggests the Fuji deal won't get done. While it would be nice to see at least one of those other 'commercial discussions' emerge into the harsh light of day, the content and tone of this report reaffirms my view that CYP is a long term hold for big upside. I emphasise long term - if stem cell medicine is to be a big part of Western medicine's future, it's going to be a long journey. Currently we are driving the bus.
OOO
Ann: June 2019 Quarterly Report, page-2
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.0¢ | $16.13K | 84.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18330 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 43657 | 1 |
View Market Depth
| Last trade - 15.57pm 04/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |